Education
About Us
Working with TipRanks
Follow Us
OWC Pharmaceutical Research Corp (OWCP)
OTHER OTC:OWCP
Total Valuation
OWC Pharmaceutical Research has a market cap or net worth of $497.00. The enterprise value is -$3.46M.
Market Cap$497.00
Enterprise Value-$3.46M
Share Statistics
OWC Pharmaceutical Research has 497,498,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding497,498,350
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OWC Pharmaceutical Research’s return on equity (ROE) is 1.09 and return on invested capital (ROIC) is -137.91%.
Return on Equity (ROE)1.09
Return on Assets (ROA)-2.89
Return on Invested Capital (ROIC)-137.91%
Return on Capital Employed (ROCE)-1.38
Revenue Per Employee0.00
Profits Per Employee-1.14M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OWC Pharmaceutical Research is ―. OWC Pharmaceutical Research’s PEG ratio is -1.24.
PE Ratio―
PS Ratio0.00
PB Ratio-162.34
Price to Fair Value-162.34
Price to FCF-606.45
Price to Operating Cash Flow>-0.01
PEG Ratio-1.24
Income Statement
In the last 12 months, OWC Pharmaceutical Research had revenue of 0.00 and earned -10.26M in profits. Earnings per share was -0.07.
Revenue0.00
Gross Profit―
Operating Income-4.30M
Pretax Income-10.26M
Net Income-10.26M
EBITDA-3.56M
Earnings Per Share (EPS)-0.07
Cash Flow
In the last 12 months, operating cash flow was -2.74M and capital expenditures -7.04K, giving a free cash flow of -2.75M billion.
Operating Cash Flow-2.74M
Free Cash Flow-2.75M
Free Cash Flow per Share>-0.01
Dividends & Yields
OWC Pharmaceutical Research pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
OWC Pharmaceutical Research upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
OWC Pharmaceutical Research as a current ratio of 8.03, with Debt / Equity ratio of 0.00%
Current Ratio8.03
Quick Ratio8.03
Debt to Market Cap0.00
Net Debt to EBITDA0.97
Interest Coverage Ratio-1.43K
Taxes
In the past 12 months, OWC Pharmaceutical Research has paid 3.00K in taxes.
Income Tax3.00K
Effective Tax Rate>-0.01
Enterprise Valuation
OWC Pharmaceutical Research EV to EBITDA ratio is -429.02, with an EV/FCF ratio of -605.07.
EV to Sales0.00
EV to EBITDA-429.02
EV to Free Cash Flow-605.07
EV to Operating Cash Flow-611.85
Balance Sheet
OWC Pharmaceutical Research has $1.47M in cash and marketable securities with $47.00K in debt, giving a net cash position of $1.42M billion.
Cash & Marketable Securities$1.47M
Total Debt$47.00K
Net Cash$1.42M
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for OWC Pharmaceutical Research is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―